Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3216135
Max Phase: Preclinical
Molecular Formula: C24H44Cl2N4
Molecular Weight: 386.63
Molecule Type: Small molecule
Associated Items:
ID: ALA3216135
Max Phase: Preclinical
Molecular Formula: C24H44Cl2N4
Molecular Weight: 386.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.c1cn(CCCCCCCCCCCCCCCCCCn2ccnc2)cn1
Standard InChI: InChI=1S/C24H42N4.2ClH/c1(3-5-7-9-11-13-15-19-27-21-17-25-23-27)2-4-6-8-10-12-14-16-20-28-22-18-26-24-28;;/h17-18,21-24H,1-16,19-20H2;2*1H
Standard InChI Key: RLCVJIZLDJFWAN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 386.63 | Molecular Weight (Monoisotopic): 386.3409 | AlogP: 7.02 | #Rotatable Bonds: 19 |
Polar Surface Area: 35.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 6.84 | CX LogP: 6.79 | CX LogD: 6.71 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.24 | Np Likeness Score: -0.56 |
1. Gao Y, Vlahakis JZ, Szarek WA, Brockhausen I.. (2013) Selective inhibition of glycosyltransferases by bivalent imidazolium salts., 21 (5): [PMID:23375091] [10.1016/j.bmc.2012.12.034] |
2. Crandall IE, Zhao B, Vlahakis JZ, Szarek WA.. (2013) The interaction of imidazole-, imidazolium-, and tetrazolium-containing compounds with DNA., 23 (5): [PMID:23375791] [10.1016/j.bmcl.2012.11.106] |
Source(1):